APP and COVID-19: It has been reported that in APP/PS1 transgenic mice, the S2 subunit of the SARS-CoV-2 S protein can interact with the γ-secretase complex, enhancing γ-secretase cleavage of APP to accelerate the production of Aβ, thereby promoting the emergence of COVID-19 neuropathological changes [77] (Fig. 3G).